Antipsychotic Medication

Size: px
Start display at page:

Download "Antipsychotic Medication"

Transcription

1 Antipsychotic Medication Mary Knutson, RN Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1

2 Clinical Uses of Antipsychotics Short-term: in severe depression and in substance-induced psychosis Treatment of aggressiveness and behavioral problems with pervasive developmental disorders Useful in elderly patients with dementia; delirium with agitation and psychosis Decrease vocal tics in Tourette syndrome Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 2

3 Phenothiazines Typical Antipsychotics Chlorpromazine (Thorazine), thioridazine (Mellaril), mesoridazine (Serentil), perphenazine (Trilafon), trifluoperazine (Stelazine), fluphenazine (Prolixin) Thiothixene (Navane) Butyrophenone: haloperidol (Haldol) Dibenzoxazepine: loxapine (Loxitane) Dihydroindolone: molindone (Moban) Diphenylbutylpiperidine: pimozide (Orap) Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 3

4 Atypical Antipsychotics Aripiprazole (Abilify) Clozapine (Clozaril) Paliperidone (Invega) Risperidone (Risperdal, Consta, M-Tabs) Olanzapine (Zyprexa, Zydis) Quetiapine (Seroquel) Ziprasidone (Geodon) Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 4

5 Target Symptoms for Antipsychotics Positive symptoms: excess or distortion of normal function Psychotic disorders of thinking: delusions or hallucinations Disorganization of speech and behavior: thought disorder (incoherence, derailment, illogicality), bizarre behavior Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 5

6 Target Symptoms for Antipsychotics Mood symptoms Cognitive impairment Difficulty with socialization Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 6

7 Target Symptoms for Atypical Antipsychotics Negative symptoms: decrease or loss of normal function Flattened affect Alogia (restricted thought and speech) Avolition/apathy Anhedonia/asociality Attentional impairment Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 7

8 Treatment Plan Initial nursing treatment plan should address target symptoms; selection of drug, dose, response, observed side effects and their treatment; patient safety, education, reassurance Nurse-patient relationship forms basis for ongoing therapeutic alliance Nonpharmacological treatment of residual symptoms of psychosis more successful when patient s behavior, mood, and thought processes begin to improve with medications Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 8

9 Drug Action of Atypical Antipsychotics Block at dopamine 2 (D 2 ) and serotonin 2 (5-HT 2 ) postsynaptic receptors; thus they are DA and 5- HT antagonists Aripiprazole: new generation of atypical antipsychotics, a dopamine-serotonin stabilizer; partial agonist (enhancer) at D 2 and 5-HT 1A receptors and has antagonistic (blocking) activity at 5-HT 2A receptors Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 9

10 Advantages of Atypical Antipsychotics Improve positive symptoms of schizophrenia, but unlike typical drugs, they also improve negative symptoms Atypical drugs reported to treat mood symptoms, hostility, violence, suicidal behavior, difficulty with socialization, cognitive impairment seen in schizophrenia Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 10

11 Disadvantages of Atypical Drugs Can result in metabolic syndrome Problems with this syndrome: weight gain, diabetes, and dyslipidemia, often resulting in cardiovascular disease Higher cost compared with typical antipsychotics However, cost/benefit analyses show cost outweighed by improved effectiveness and quality of life of patients taking these drugs Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 11

12 Side Effects of Atypical Antipsychotics Risperidone: elevate serum prolactin levels; may cause extrapyramidal symptoms (EPS) at higher doses Weight gain and metabolic disturbances; side effects (except ziprasidone and aripiprazole); olanzapine and clozapine highest likelihood of causing problems Sedation commonly observed in patients taking quetiapine, olanzapine, or clozapine Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 12

13 Side Effects Because ziprasidone associated with mild/moderate prolonged Q-T interval, may need monitoring of ECGs and cardiac functioning Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 13

14 Side Effects Clozapine often reserved for patients with treatment-resistant illness because of side effects: agranulocytosis, seizures, myocarditis Prescribers must follow treatment protocol, entering patients in national registry, monitoring WBC count every 1-2 weeks, and writing prescriptions for maximum of 2 weeks Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 14

15 Drug Action of Typical Antipsychotics Dopamine (DA) antagonists: they block postsynaptic D 2 receptors in several DA tracts in brain; decrease in positive symptoms of schizophrenia and EPS Have synaptic effects in other transmitter systems; broad side effect profile Selection of drug determined by extent, type, severity of side effects Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 15

16 Drug Action A low-potency drug (chlorpromazine) reduces risk of EPS; high-potency drug (haloperidol) minimizes sedation, postural hypotension, anticholinergic effects Have not been particularly effective in treating cognitive impairment and mood symptoms, the other dimensions of schizophrenia Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 16

17 Side Effects of Antipsychotics Discomfort to life-threatening emergency EPS Acute dystonic reactions Akathisia Parkinson syndrome Neuroleptic malignant syndrome (NMS) Seizures Agranulocytosis Photosensitivity, anticholinergic effects, or metabolic syndrome Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 17

18 Extrapyramidal Symptoms EPS and tardive dyskinesia: side effects of typical antipsychotics Result in patient nonadherence with drug EPS common and often painful, disabling Also stigmatizing but usually can be prevented or minimized and effectively treated, except for tardive dyskinesia, which may remain Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 18

19 Extrapyramidal Side Effects Mimic extrapyramidal disease by causing: Involuntary movement Changes in muscle tone Abnormal posture May resemble Parkinson disease Caused by drugs that block dopamine receptor sites Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 19

20 Acute Dystonic Reactions Sudden spasms of major muscle groups that are frightening and painful They may need treatment with medication Occur mostly with high-potency drugs or with abrupt withdrawal Oculogyric crisis is when eyes stay in an up or sideways position for minutes or several hours Torticolis is when head is inclined to one side involuntarily because of muscle contractions Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 20

21 Akathisia Inability to remain still Pacing Inner restlessness Leg aches relieved by movement Need to rule out anxiety or agitation, then medicate patient Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 21

22 Parkinson Syndrome Akinesia: abnormal state of hypoactivity or muscle paralysis Cogwheel rigidity: abnormal rigor in muscle tissue, including jerky movements when muscle passively stretched Fine tremor: quick, rhythmic, quivering movements that sometimes disappear during purposeful movements Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 22

23 Tardive Dyskinesia (TD) Can occur after use (usually long use) of conventional antipsychotics Involuntary movements: tongue protrusion, lip smacking, chewing, blinking, grimacing, choreiform movements of limbs and trunk, foot tapping Use preventive measures, and assess often Consider changing to atypical antipsychotic because there is no treatment for TD Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 23

24 Treatment Principles Tolerance to side effects usually develops by third month Decrease dose of drug May add a drug to treat EPS, then taper after 3 months on antipsychotic Use a drug with lower EPS profile Give patient education, support Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 24

25 Drug Strategies to Treat EPS Administer one of these drugs: Anticholinergics: benztropine (Cogentin), trihexyphenidyl (Artane), biperiden (Akineton), procyclidine (Kemadrin) Antihistamine: diphenhydramine (Benadryl) Dopamine agonist: amantadine (Symmetrel) Benzodiazepines: diazepam (Valium), lorazepam (Ativan), clonazepam (Klonopin) Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 25

26 Neuroleptic Malignant Syndrome Rare but potentially fatal (14%-30% mortality) side effect of antipsychotic drugs Fever, tachycardia, sweating, muscle rigidity, tremor, incontinence, stupor Treatment: stop triggering drug, initiate supportive care Important reason for nurse to assess carefully for drug side effects Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 26

27 Other Side Effects of Anticholinergic effects Antipsychotics Constipation, dry mouth, blurred vision, orthostatic hypotension, tachycardia, urinary retention, nasal congestion Metabolic syndrome Weight gain, diabetes, and dyslipidemia, often resulting in cardiovascular disease Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 27

28 General Pharmacological Principles Dosage requirements for individual patients vary considerably, must be adjusted as target symptoms change and side effects monitored Some patients begin to respond to sedating effects of typical drugs in 2-3 days, some take as long as 2 weeks Full benefits may take 4 or more weeks Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 28

29 Drug Effects Atypical drugs may begin to work in 1 week but take several months to reach maximum efficacy Thus patient, family, and clinician must not increase dose prematurely because this strategy usually increases side effects and not effectiveness Brief course of benzodiazepine may help patient maintain control during this time Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 29

30 Changing Drug Therapy Patient unresponsive to antipsychotic trial often responds to another antipsychotic in a second trial Clozapine is usually considered only after second trial failure (when patient is considered treatment resistant) When switching from one antipsychotic to another, gradually decrease one drug while gradually increasing new drug (cross-titration) over 2-4 days Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 30

31 Preparations of Antipsychotics Several typical (haloperidol) and atypical (ziprasidone) antipsychotics have short-acting injectable preparation, can be administered IM in acutely agitated patients Often provides relief for acutely ill patient while oral formulations begin to work or until acute crisis resolved Some in oral disintegrating tablet form Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 31

32 Maintenance Treatment May include injectable preparations if patient unable to adhere adequately to daily dosing regimen Long-acting (haloperidol decanoate, fluphenazine decanoate, Risperdal Consta) typical and atypical drugs available Test ability to tolerate first by administering oral form for several days, then administering injection that may last for many weeks Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 32

33 Antipsychotics Taper slowly over days to weeks to avoid dyskinetic reactions and side effects Do not cause chemical dependency or tolerance to antipsychotic effects Low abuse potential; safe in overdose Effects on fetus inconclusive, but must consider what is best for pregnant mother Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 33

34 Role of Nurse Minimize patient s fears Decrease any sense of stigmatization Enhance adherence to drug treatment Provide effective patient education Support patient, family Manage intensive, comprehensive medication regimen Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 34

35 References Stuart, G. (2009). Principles and practices of Psychiatric Nursing (9 th ed.) St. Louis: Mosby Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 35

ANTIPSYCHOTICS/ NEUROLEPTICS

ANTIPSYCHOTICS/ NEUROLEPTICS Pharmacological Interventions Tutorial Antipsychotic medications First Generation (Typicals) Includes phenothiazines, thioxanthenes, butyrophenones ANTIPSYCHOTICS/ NEUROLEPTICS Second Generation (Atypicals)

More information

What Team Members Other Than Prescribers Need To Know About Antipsychotics

What Team Members Other Than Prescribers Need To Know About Antipsychotics What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State

More information

Chapter 161 Antipsychotics

Chapter 161 Antipsychotics Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in

More information

Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM

Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the result of dopamine binding to D2 receptors

More information

Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses

Chapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode

More information

Extrapyramidal Symptoms Associated with Antipsychotic Use

Extrapyramidal Symptoms Associated with Antipsychotic Use Extrapyramidal Symptoms Associated with Antipsychotic Use Tamara Pringsheim, MD, FRCPC, FAAN Associate Professor, University of Calgary Department of Clinical Neurosciences, Psychiatry, Pediatrics and

More information

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Associate Professor of Psychiatry University of Michigan Pretest 1. Appropriate target symptoms for emergency room medication treatment

More information

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition

Objectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change

More information

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia

Objectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used

More information

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan

Psychopharmacology in the Emergency Room. Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Psychopharmacology in the Emergency Room Michael D. Jibson, M.D., Ph.D. Professor of Psychiatry University of Michigan Pretest 1. Which of the following conditions is LEAST likely to benefit from emergency

More information

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering

Treat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering Robert M. Millay RN MSN Ed Professor, Napa Valley College Psychiatric Technician Programs Copyright 2015, 2011, 2007, 2003, 1999, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Treat Schizophrenia Schizoaffective

More information

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET

HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS

More information

Mellaril (thioridazine)

Mellaril (thioridazine) Generic name: Thioridazine Available strengths: 10 mg, 25 mg, 50 mg, 100 mg, 200 mg tablets; 30 mg/ml, 100 mg/ml oral concentrate Available in generic: Yes Drug class: First-generation (conventional) antipsychotic

More information

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh

How did we get here? 1876 Methylene Blue. Insecticide 1935 Du Pont Anthelmintic. Garrett McCann, RPh Polypharmacy, Adverse Effects, and the Importance of Tapering Medications for People with Intellectual and Developmental Disabilities Garrett McCann, RPh How did we get here? 1876 Methylene Blue Insecticide

More information

Antipsychotic Use in the Elderly

Antipsychotic Use in the Elderly Antipsychotic Use in the Elderly Presented by: Fatima M. Ali, PharmD, RPh, BCPS Clinical Consultant Pharmacist MediSystem Pharmacy, Kingston Originally Prepared by: Nicole Tisi BScPhm, RPh ACPR Disclosure

More information

CHAPTER 3. Schizophrenia and Antipsychotic Treatment

CHAPTER 3. Schizophrenia and Antipsychotic Treatment CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia

More information

Antipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1

Antipsychotics. Neuroleptics/ Major Tranquilizers. Hiwa K. Saaed, PhD Pharmacology & Toxicology /5/18 1 Antipsychotics Neuroleptics/ Major Tranquilizers Hiwa K. Saaed, PhD Pharmacology & Toxicology hiwa.saaed@univsul.edu.iq 2018-2019 12/5/18 1 Learning objectives Pharmacy students should: be familiar with

More information

The alternate reality of schizophrenia

The alternate reality of schizophrenia The alternate reality of schizophrenia MICHAEL TRINSEY SCHIZOPHRENIA IS A GROUP of chronic, disabling psychiatric disorders characterized by disturbed thinking and disorganized speech. Patients with schizophrenia

More information

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis

Psychiatric Illness. In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis Psychiatric Illness In the medical arena psychiatry is a fairly recent field A challenging field Numerous diagnosis 12,000,000 children infants through 18 y/o nation wide 5,000,000 suffer severely Serious

More information

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer

A Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.

More information

SCHIZOPHRENIA AND PSYCHOSIS MODULE III RNSG 2213

SCHIZOPHRENIA AND PSYCHOSIS MODULE III RNSG 2213 SCHIZOPHRENIA AND PSYCHOSIS MODULE III RNSG 2213 SCHIZOPHRENIA: OVERVIEW Major Axis I disorder Characterized by disturbances in: Perception Thought processes and reality testing Affect (feelings) Behavior

More information

The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1

The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1 The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1 Contributors Dr. Francesca Falzon Aquilina; BST psychiatry Dr Claire Axiaq; Resident

More information

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients

Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine

More information

ANTIPSYCHOTICS AGENTS CONVENTIONAL

ANTIPSYCHOTICS AGENTS CONVENTIONAL ANTIPSYCHOTICS AGENTS CONVENTIONAL Documentation A. FDA approved indications 1. Psychotic Disorder (Haloperidol, Thiothixene) 2. Schizophrenia 3. Bipolar Disorder, Manic (Chlorpromazine) 4. Severe Behavioral

More information

APPROACH TO PSYCHOSIS IN PRIMARY CARE

APPROACH TO PSYCHOSIS IN PRIMARY CARE APPROACH TO PSYCHOSIS IN PRIMARY CARE Family Medicine Forum 2015 Annual Meeting Toronto, Ontario November 12-14, 2015 Jon Davine, MD, CCFP, FRCP(C) Associate Professor, McMaster University Objectives

More information

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017

Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017 Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic

More information

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics

Slide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Slide 1 Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Flavio Guzmán, MD Slide 2 About this module 13 antipsychotics will be studied 3 first generation antipsychotics 10 second

More information

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course)

Review of Psychotrophic Medications. (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Review of Psychotrophic Medications (An approved North Carolina Division of Health Services Regulation Continuing Education Course) Common Psychiatric Disorders *Schizophrenia *Depression *Bipolar Disorder

More information

THIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes

THIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy

More information

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08.

Clinical Policy: Olanzapine Long-Acting Injection (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: Last Review Date: 08. Clinical Policy: (Zyprexa Relprevv) Reference Number: CP.PHAR.292 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy for important

More information

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS

SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the

More information

Schizophrenia and Related Psychotic Disorders

Schizophrenia and Related Psychotic Disorders and Related Psychotic Disorders Anand K. Pandurangi, MD Professor & Chair, Div. of Inpatient Psychiatry Director, Program VCU Medical Center 1 Kraeplin 1896 Dementia Praecox. Single, Homogenous Disorder

More information

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused

Treat mood, cognition, and behavioral disturbances associated with psychological disorders. Most are not used recreationally or abused Psychiatric Drugs Psychiatric Drugs Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally or abused Benzodiazepines

More information

Schizophrenia and Antipsychotic Medications

Schizophrenia and Antipsychotic Medications Schizophrenia and Antipsychotic Medications Model Curriculum Michael D. Jibson, M.D., Ph.D. Ira D. Glick, M.D. American Society for Clinical Psychopharmacology Pretest 1. Negative symptoms of schizophrenia

More information

Family Medicine Forum November 10, 2017 Montreal. Quebec. Jon Davine, CCFP, FRCP(C) McMaster University

Family Medicine Forum November 10, 2017 Montreal. Quebec. Jon Davine, CCFP, FRCP(C) McMaster University APPROACH TO PSYCHOSIS IN PRIMARY CARE Family Medicine Forum November 10, 2017 Montreal. Quebec. Jon Davine, CCFP, FRCP(C) McMaster University DISCLOSURE Speaker/Presenter Disclosure Not applicable Disclosure

More information

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues

Antipsychotics. Something Old, Something New, Something Used to Treat the Blues Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer

More information

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer

PSYCHIATRIC DRUGS. Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Mr. D.Raju, M.pharm, Lecturer PSYCHIATRIC DRUGS Treat mood, cognition, and behavioral disturbances associated with psychological disorders Psychotropic in nature Most are not used recreationally

More information

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)

Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Introduction Antipsychotics are the foundation of pharmacological treatment of schizophrenia and other psychotic illnesses.

More information

Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University

Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University Charles P. Samenow, MD, MPH Department of Psychiatry George Washington University Objectives Identify the epidemiology, symptomatology, course, causality (including genetic risk) and treatment options

More information

Care of the Acutely Agitated Patient. Objectives. Agitation Defined

Care of the Acutely Agitated Patient. Objectives. Agitation Defined Care of the Acutely Agitated Patient James C. Hardy, MD Assistant Professor of Emergency Medicine Department of Emergency Medicine, UCSF Dealing with combative patients is one of the most difficult challenges

More information

Devon A. Sherwood, PharmD, BCPP Assistant Professor of Pharmacy Practice

Devon A. Sherwood, PharmD, BCPP Assistant Professor of Pharmacy Practice Devon A. Sherwood, PharmD, BCPP Assistant Professor of Pharmacy Practice Differentiate dopamine neurotransmitter pathways associated with antipsychotic medications Identify therapy challenges associated

More information

Treatment of Schizophrenia

Treatment of Schizophrenia Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,

More information

Schizophrenia. Clinical presentation: Factors affecting diagnosis and prognosis

Schizophrenia. Clinical presentation: Factors affecting diagnosis and prognosis Schizophrenia 30 Schizophrenia is one of the most complex and challenging of psychiatric disorders. It represents a heterogeneous syndrome of disorganized and bizarre thoughts, delusions, hallucinations,

More information

The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in

The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in Antipsychotic Drugs The antipsychotic drugs (also called neuroleptics or major tranquilizers) are used primarily to treat schizophrenia, but they are also effective in other psychotic and manic states.

More information

PERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes

PERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes PERPHENAZINE THERAPEUTICS Brands Trilafon see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine receptor antagonist (D-RAn) Conventional antipsychotic (neuroleptic,

More information

TRIFLUOPERAZINE. THERAPEUTICS Brands Stelazine see index for additional brand names

TRIFLUOPERAZINE. THERAPEUTICS Brands Stelazine see index for additional brand names TRIFLUOPERAZINE THERAPEUTICS Brands Stelazine see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine receptor antagonist (D-RAn) Conventional antipsychotic (neuroleptic,

More information

Antidepressants. Dr Malek Zihlif

Antidepressants. Dr Malek Zihlif Antidepressants The optimal use of antidepressant required a clear understanding of their mechanism of action, pharmacokinetics, potential drug interaction and the deferential diagnosis of psychiatric

More information

Dosing & Administration

Dosing & Administration Dosing & Administration REAL LIFE. REAL RESULTS. INDICATION INVEGA SUSTENNA (paliperidone palmitate) is indicated for the treatment of: Schizophrenia. Schizoaffective disorder as monotherapy and as an

More information

Subject Review. Antipsychotic Agents: A Clinical Update

Subject Review. Antipsychotic Agents: A Clinical Update Subject Review Antipsychotic Agents: A Clinical Update JOHN L. BLACK, M.D., Department of Psychiatry and Psychology; ELLIOTT RICHELSON, M.D., Department of Psychiatry and Psychology and Department of Pharmacology;

More information

See Important Reminder at the end of this policy for important regulatory and legal information.

See Important Reminder at the end of this policy for important regulatory and legal information. Clinical Policy: (Abilify Maintena, Aristada, Aristada Initio) Reference Number: CP.PHAR.290 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid Coding Implications Revision Log

More information

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness

First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness 1 First-Generation Versus Second-Generation Antipsychotics in Adults: Comparative Effectiveness This continuing education monograph examines the results of a comparative effectiveness review to compare

More information

Antipsychotic Medications

Antipsychotic Medications TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood

More information

Antipsychotics. This factsheet covers -

Antipsychotics. This factsheet covers - Antipsychotics If you experience psychosis as part of an illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar disorder

More information

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials

Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials SPEAKER NOTES Overview and Update on Current Psychopharmacological Medications, Including New Medications in Clinical Trials Summarized by Thomas T. Thomas New psychotropic medications are coming on the

More information

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination)

Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Symbyax (Zyprexa [olanzapine] and Prozac [fluoxetine] combination) Generic name: Olanzapine and fluoxetine combination Available strengths: 6 mg/25 mg, 6 mg/50 mg, 12 mg/25 mg, 12 mg/50 mg (Zyprexa/Prozac)

More information

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS

Pharmacy Benefit Management (PBM) Program FORMULARY/PRODUCT RESTRICTIONS Workforce Safety & Insurance Revised Document Date: 07/21/2015 1600 E Century Ave Ste 1 PO Box 5585 Bismarck, ND 58506-5585 701.328.3800 1.800.777.5033 www.workforcesafety.com Pharmacy Benefit Management

More information

This factsheet covers:

This factsheet covers: Antipsychotics If you experience psychosis as part of your illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar

More information

PERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes

PERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes PERPHENAZINE THERAPEUTICS Brands Trilafon see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, antiemetic) Commonly Prescribed

More information

Antipsychotic Medications Age and Step Therapy

Antipsychotic Medications Age and Step Therapy Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana

More information

Study Guidelines for Quiz #1

Study Guidelines for Quiz #1 Annex to Section J Page 1 Study Guidelines for Quiz #1 Theory and Principles of Psychopharmacology, Classifications and Neurotransmitters, Anxiolytics/Antianxiety/Minor Tranquilizers, Stimulants, Nursing

More information

Schizophrenia and schizophrenia-like disorders

Schizophrenia and schizophrenia-like disorders Schizophrenia and schizophrenia-like disorders Dr: Weibo Liu E-mail:liuweibo1020@163.com The Second Affiliated Hospital Zhejiang University College of Medicine Category of psychotic disorders Schizophrenia

More information

Medications and Children Disorders

Medications and Children Disorders Mental Health Comprehensive Services Providing Family Stability and Developing Life Coping Skills Medications and Children Disorders Psychiatric medications can be an effective part of the treatment for

More information

Schizophrenia Therapeutics III Fall 2003 Michael McGuire, Pharm.D., BCPP

Schizophrenia Therapeutics III Fall 2003 Michael McGuire, Pharm.D., BCPP Schizophrenia Therapeutics III Fall 2003 Michael McGuire, Pharm.D., BCPP Required Reading: 1. Fankhauser MP. Schizophrenia. In DiPiro JT ed. Pharmacotherapy: A pathophysiologic approach. 5th ed. New York:

More information

10/2/2017. Evaluate existing data in regards to the appropriate treatment of schizophrenia

10/2/2017. Evaluate existing data in regards to the appropriate treatment of schizophrenia Evaluate existing data in regards to the appropriate treatment of schizophrenia Review risks and benefits of antipsychotic therapy in the management of acute psychosis Rebecca L. Jones, Pharm.D., B.C.P.P.

More information

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics

Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives

More information

Schizophrenia - The Pharmacist s Role (Diagnosis, Treatment Options, and Outcomes)

Schizophrenia - The Pharmacist s Role (Diagnosis, Treatment Options, and Outcomes) Schizophrenia - The Pharmacist s Role (Diagnosis, Treatment Options, and Outcomes) Elizabeth Montagnese, M.D. Adult, Child and Adolescent Psychiatrist Private Practitioner This program has been supported

More information

Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine)

Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Potential Nursing Diagnoses Ineffective Therapeutic Regimen Management Risk for Activity Intolerance, related to side effect of drug

More information

Antipsychotics & Anxiolytics

Antipsychotics & Anxiolytics Psychotropic Medications Series Part 2: Antipsychotics & Anxiolytics Terry Broda, RN(EC), BScN, NP-PHC, CDDN Elizabeth Kacew, RN(EC), MScN, NP-PHC September 22, 2014 Antipsychotics & Anxiolytics Between

More information

Asenapine GENERAL INFORMATION DOSING INFORMATION. Available in generic

Asenapine GENERAL INFORMATION DOSING INFORMATION. Available in generic Asenapine Generic name Available brand Available strengths and formulations Available in generic Asenapine Saphris 5-mg and 10-mg sublingual tablets No GENERAL INFORMATION Asenapine (Saphris) is an antipsychotic

More information

Medication Audit Checklist- Antipsychotics - Atypical

Medication Audit Checklist- Antipsychotics - Atypical Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,

More information

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology

Elements for a Public Summary. VI.2.1 Overview of disease epidemiology VI.2 Elements for a Public Summary VI.2.1 Overview of disease epidemiology Schizophrenia Schizophrenia is a mental disorder often characterized by abnormal social behaviour and failure to recognize what

More information

Ativan and geodon compatibility

Ativan and geodon compatibility P ford residence southampton, ny Ativan and geodon compatibility In this case, a patient developed severe hypotension (66/30 mm Hg) after receiving intramuscular olanzapine and intramuscular lorazepam

More information

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications

Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy

More information

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009

Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric

More information

COALINGA STATE HOSPITAL. Effective Date: August 31, 2006

COALINGA STATE HOSPITAL. Effective Date: August 31, 2006 COALINGA STATE HOSPITAL NURSING POLICY AND PROCEDURE MANUAL SECTION Emergency Procedures POLICY NUMBER: 717 Effective Date: August 31, 2006 SUBJECT: NEUROLEPTIC MALIGNANT SYNDROME 1. PURPOSE: To provide

More information

Update on Psychoses and Schizophrenia

Update on Psychoses and Schizophrenia Home-Study Continuing Pharmacy Education Modules for Pharmacy Technicians April 2012 Volume 17 Number 2 Update on Psychoses and Schizophrenia This module must be successfully completed by April 30, 2014

More information

Seniors Health Strategic Clinical Network Restraint as a Last Resort

Seniors Health Strategic Clinical Network Restraint as a Last Resort Seniors Health Strategic Clinical Network Restraint as a Last Resort Elder Friendly Care 2018 Alberta Health Services, Seniors Health Strategic Clinical Network Disclaimer, Copyright and Creative Commons

More information

Assessing & Management of side effects: Part 1. medicationmanagement

Assessing & Management of side effects: Part 1. medicationmanagement Assessing & Management of side effects: Part 1 medicationmanagement What side effects of antipsychotic medication do you see in you clinical practice? How do you routinely assess for side effects of medication?

More information

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members

IMPORTANT NOTICE. Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members IMPORTANT NOTICE Changes to dispensing of some Behavioral Health Medications for DC Healthcare Alliance members These changes apply only to members covered under the DC Healthcare Alliance program Alliance

More information

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009

SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009 MIT OpenCourseWare http://ocw.mit.edu SP.236 / ESG.SP236 Exploring Pharmacology Spring 2009 For information about citing these materials or our Terms of Use, visit: http://ocw.mit.edu/terms. Atypical (2

More information

Psychiatric Medication Guide

Psychiatric Medication Guide Psychiatric Medication Guide F O R : N E O N P R I M A R Y H E A L T H C A R E P R O V I D E R S B Y : M I C H E L L E R O M E R O, D O M A Y, 2 0 1 3 Anti-depressants TCA s & MAOI s (Tricyclic Antidepressants

More information

Latuda (lurasidone) Summary of the Risk Management Plan (RMP) for the Public

Latuda (lurasidone) Summary of the Risk Management Plan (RMP) for the Public Latuda (lurasidone) Summary of the Risk Management Plan (RMP) for the Public An introduction to Risk Management Plans When a medicine is approved, the patient leaflet gives information about the side effects

More information

What would you think?

What would you think? What would you think? Would you administer a medication to a patient if you were warned by the FDA that by giving it you have increased this resident s risk of death? Strategies in Psychoactive Medication

More information

Antipsychotics. BMF 84 - Antipsychotics

Antipsychotics. BMF 84 - Antipsychotics Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms

More information

Abbreviated Class Review: Long-Acting Injectable Antipsychotics

Abbreviated Class Review: Long-Acting Injectable Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Psychosis, Delirium, Dementia

Psychosis, Delirium, Dementia Psychosis, Delirium, Dementia Melinda M. Spencer Smith, DNP, ACNS-BC, APRN Bertia A. Spencer Jennings, DNP, PPCNP, PMHS, BC Intentions and Limitations of Training Introduction Psychosis, Delirium, Dementia

More information

Abbreviated Class Review: Long-Acting Injectable Antipsychotics

Abbreviated Class Review: Long-Acting Injectable Antipsychotics Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119

More information

Riding the Waves: Tools for the Management of Bipolar Disorder

Riding the Waves: Tools for the Management of Bipolar Disorder Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School

More information

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed)

Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) Antipsychotics Detect, Select, Effect (P.I.E.C.E.S. 6 th Ed) CLeAR Webinar February 14, 2014 Paula Diaz (Pharm) Carol Ward MD Carol Ward Tertiary Mental Health IHA Hillside Centre (Acute Tertiary Mental

More information

Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole)

Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole) EMA/370707/2016 Summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma (aripiprazole) This is a summary of the risk management plan (RMP) for Aripiprazole Mylan Pharma, which details the

More information

LOXAPINE. THERAPEUTICS Brands Loxitane Adasuve (Staccato loxapine, inhaled loxapine) see index for additional brand names. Generic?

LOXAPINE. THERAPEUTICS Brands Loxitane Adasuve (Staccato loxapine, inhaled loxapine) see index for additional brand names. Generic? LOXAPINE THERAPEUTICS Brands Loxitane Adasuve (Staccato loxapine, inhaled loxapine) see index for additional brand names Generic? Yes Class Neuroscience-based Nomenclature: dopamine and serotonin receptor

More information

Chapter Chapter Chapter Chapter Chapter Chapter Chapter Chapter 8 Chapter

Chapter Chapter Chapter Chapter Chapter Chapter Chapter Chapter 8 Chapter CONTENTS Preface Chapter 1 Principles of Chemical Neurotransmission Chapter 2 Receptors and Enzymes as the Targets of Drug Action Chapter 3 Special Properties of Receptors Chapter 4 Chemical Neurotransmission

More information

First Steps: Considering Clozapine for your Patients

First Steps: Considering Clozapine for your Patients First Steps: Considering Clozapine for your Patients The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health

More information

Biological Psych Schizophrenia

Biological Psych Schizophrenia Biological Psych Schizophrenia Psychotic disorders The Schizophrenias 1% incidence More likely in US & Europe 10 to 100 times Slightly more common in men Earlier onset, more severe Originally: dementia

More information

Antipsychotic Medication: Monitoring Side Effects

Antipsychotic Medication: Monitoring Side Effects Antipsychotic Medication: Monitoring Side Effects Aims Review national practice guidelines and evidence regarding current standards of care. Discuss clinical implications of AP side effects. Reflect on

More information

Michael J. Bailey, M.D. OptumHealth Public Sector

Michael J. Bailey, M.D. OptumHealth Public Sector Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)

More information

Guide to Psychiatric Medications for Children and Adolescents

Guide to Psychiatric Medications for Children and Adolescents Guide to Psychiatric Medications for Children and Adolescents by Glenn S. Hirsch, M.D. The following guide includes most of the medications used to treat child and adolescent mental disorders. It lists

More information